Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Antidepresivi (CROSBI ID 162884)

Prilog u časopisu | stručni rad

Rajić, Zrinka Antidepresivi // Farmaceutski glasnik, 66 (2010), 3; 133-146

Podaci o odgovornosti

Rajić, Zrinka

hrvatski

Antidepresivi

Depression is a mental condition in which one feels exhausted, worthless, helpless, hopeless and desperate. It affects 10–12 % of the Western population. Without treatment, symptoms can last for weeks, monts and years. Appropriate treatment can help most people who suffer from depression. The antidepressant class of drugs are well-known and widely used today. They are classified according to their principal mechanism of action: selective norepinefrine reuptake inhibitors (SNRI), selective serotonin reuptake inhibitors (SSRI), norepinefrine and serotonin reuptake inhibitors (NSRI), dopamin and norepinefrine reuptake inhibitors (DNRI), serotonin receptor modulators (SARI and NaSSA) and monoamine oxidase inhibitors (MAOI). New generations of antidepressants, such as SSRIs, have more favourable side effect and pharmacokinetic profiles then the older generations of antidepressants, which has resulted in improved patient compliance and therapeutic outcomes for patients with major depressive disorder.

depresija; neurotransmitori; lijekovi; antidepresivi

nije evidentirano

engleski

Antidepressants

nije evidentirano

depression; neurotransmitors; drugs; antidepressants

nije evidentirano

Podaci o izdanju

66 (3)

2010.

133-146

objavljeno

0014-8202

Povezanost rada

Farmacija

Indeksiranost